| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018681 |
| Receipt No. | R000021624 |
| Official scientific title of the study | Establishment of effective and efficient minimally invasive surgical treatment for fresh osteoporotic vertebral fracture with a poor prognostic factor - prospective multicenter intervention study - |
| Date of disclosure of the study information | 2015/08/14 |
| Last modified on | 2018/08/16 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Establishment of effective and efficient minimally invasive surgical treatment for fresh osteoporotic vertebral fracture with a poor prognostic factor
- prospective multicenter intervention study - |
|
| Title of the study (Brief title) | Early stage surgical intervention study for fresh OVF | |
| Region |
|
|
| Condition | ||
| Condition | fresh osteoporotic vertebral fracture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of minimally invasive surgery treatment(Balloon KyphoPlasty) for fresh osteoporotic vertebral fracture with a poor prognosis factor |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | ADL impairment at 6 months |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Balloon KyphoPlasty | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) osteoporotic vertebral fracture
2) Patients that can be planned surgical medical treatment within the onset 8 weeks 3) 65 years of age or older at the time of obtaining informed consent 4) poor prognostic factor in MRI findings (Diffuse low intensity or Confined high intensity in the T2 weighted image) |
|||
| Key exclusion criteria | 1) In the case of fractures difficult to use "KYPHON BKP system" (pedicle fracture and flattened vertebral, severe bone defect of posterior wall of the vertebral body, etc.)
2) a severe brain and cardiopulmonary vascular disease 3) systemic infection or local infection of fractured vertebral body 4) a hemorrhagic diathesis 5) a history of hypersensitivity to bone cement or contrast agent 6) dementia 7) malignant tumors 8) a lower limb paralysis or bladder rectal disorder |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Masatoshi Hoshino |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Orthopaedic Surgery |
| Address | 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan |
| TEL | 06-6645-3851 |
| hoshino717@gmail.com | |
| Public contact | |
| Name of contact person | Masatoshi Hoshino |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Orthopaedic Surgery |
| Address | 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan |
| TEL | 06-6645-3851 |
| Homepage URL | |
| hoshino717@gmail.com | |
| Sponsor | |
| Institute | Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021624 |